Tibayrenc, M. ed.
Encyclopedia of Infectious Diseases: Modern Methodologies
感染症百科事典
John Wiley & Sons 2007.8
747 pp. (H)
ISBN 0-471-65732-8
23,400円
Contents
1. Pulmonary Tuberculosis and Mycobacterium Tuberculosis: Modern Molecular Epidemiology and Perspectives / 2. Diseases that Threaten Livestock / 3. HIV/AIDS Infection in the World with a Special Focus on Africa / 4. Molecular-Phylogenetic Strategies for Characterization of Uncultured Pathogens / 5. Molecular or Immunological Tools for Efficient Control of Tuberculosis / 6. Understanding Human Leishmaniasis:The Need for an Integrated Approach / 7. Epidemics of Plant Diseases: Mechanisms, Dynamics and Management / 8. Malaria Vaccines / 9. The SARS Case Study:An Alarm Clock? / 10. Recombination and Its Role in the Evolution of Pathogenic Microbes / 11. Evolutionary History of the Malaria Parasites / 12. Ecology Of Infectious Diseases: An Example with Two Vaccine-Preventable Infectious Diseases / 13. Influenza Evolution / 14. Experimental Evolution of Pathogens / 15. Evolution of Antigenic Variation / 16. Hantavirus Coevolution with Their Rodent Hosts / 17. Phylogenetic Methods for the Analysis of Parasites and Pathogens / 18. Parasites that Manipulate Their Hosts / 19. Human Genetic Diversity and the Spread of Infectious Diseases / 21. The Need for Megatechnologies: Massive Sequencing, Proteomics and Bioinformatics / 22. Mathematical Modeling of Infectious Diseases Dynamics / 23. Using a Geographic Information System to Spatially Investigate Infectious Disease / 24. Vector Control by Surveillance Networks: The ECLAT Program and Chagas / 25. Contributions of Morphometrics to Medical Entomology / 26. Surveillance of Vector-Borne Diseases Using Remotely Sensed Data / 27. Archaeological Epidemiology of Infectious Diseases: Fossil DNA / 28. Insights Into Structure and Evolution of Bacterial Species That Are Revealed by Molecular Methods / 29. Exploring Genetic Relatedness, Patterns of Evolutionary Descent, and the Population Genetics of Bacterial Pathogens Using Multilocus Sequence Typing / 30. Topical Debates Evaluation of Risks and Benefits of Consumption of Antibiotics: From Individual to Public Health / 31. Epidemic Diseases in the Past: History, Philosophy, and Religious Thought / 32. Fundamentals, Domains, and Diffusion of Disease Emergence: Tools and Strategies for a New Paradigm / 33. Epidemiology in a Changing World:The Need for a Bigger Picture! / 34. Contributions of Social Anthropology to Malaria Control / 35. The Neglected Diseases and Their Economic Determinants / 36. The Challenge of Bioterrorism / 37. Needs for an Integrative Approach of Epidemics: The Example of Cholera / 38. Infectious Diseases: Market of the Future? / 39. Mobilizing the Scientific Community for the Patient’s Benefit:At the Crossroads of Fundamental and Applied Science / 40. Infectious Diseases and Arts / Index / *
* Each article is written by one or more leading experts in the field of infectious diseases. These experts place all the latest findings from various disciplines in context, helping readers understand what is currently known, what the next generation of breakthroughs is likely to be, and where more research is needed. Several features facilitate research and deepen readers' understanding of infectious diseases: *
Torrence, P. F. ed.
Combating the Threat of Pandemic Influenza
Drug Discovery Approaches
トリインフルエンザの脅威との闘い
John Wiley & Sons 2007.10
296 pp.(H)
ISBN 0-470-11879-2
14,300円
Contents
1. Existing Influenza Antivirals: The Mechanisms of Action and Potential in the Face of Avian Influenza (Erik De Clercq)/ 2. Development of High-Throughput Screening Assays for Influenza (Diana L. Noah, E. Lucile White, and James W. Noah)/ 3. Mechanisms of IFN Resistance by Influenza Virus (Heather J. Ezelle and Bret A. Hassel)/ 4. Broadly Effective Anti-Respiratory Virus Agents (Shiro Shigeta)/ 5. Current Status on Development of Nucleic Acid-based Antiviral Drugs Against Influenza Virus Inefection (Jonathan P. Wong, Mary E. Christopher, Murray Cairns, L.-Q. Sun, Roderic M.K. Dale, and Andres M. Salazar)/ 6. Antiviral RNAﾊInterface Strategies Targeting Influenza Virus and Other Respiratory Viruses (Joost Haasnoot and Ben Berkhout)/ 7. Promising Antiviral Glyco-molecules from an Edible Alga (Toshimitsu Hayashi, Kyoko Hayashi, Kenji Kanekiyo, Jung-Bum Lee, Takahisa Nakano, and Minoru Hashimoto)/ 8. Rational Design of an Anti-Adhesion Drug for Influenza (Nicolai V. Bovin and Alexandra S. Gambaryan)/ 9. Understanding Influenza Neuraminidase Inhibitors Using Quantitative Structure - Activity Relationship (QSAR) Models (Rajeshwar P. Verma and Corwin Hansch)/ 10. Peptide Inhibitors Targeting Virus-Cell Fusion in Class 1 Enveloped Viruses (George F. Gao)/ 11. Novel Influenza Therapeutics (Laura M.ﾊAschenbrenner, Nicole Pelletier, Mang Yu, and Fang Fang)/ Index/
* Priorities for combating pandemic influenza include rapid detection and identification, the quick administration of available drugs to treat the infection, the development of new antivirals, and the development of vaccines. Since lead-time may be required to produce an effective vaccine, antivirals would serve as a key first line of defense in containing an outbreak. Diverse antivirals, acting through different mechanisms, would help stay the development of resistant viruses. Thus, drug discovery for influenza antivirals is an important public health-related endeavor. *
Ramos, J.-L. & Levesque, R. C.
Pseudomonas Vol. 4
Molecular Biology of Emerging Issues
シュードモナス(緑膿菌) 第4巻
Springer-Verlag 2006.7
400 pp.(H)
ISBN 0-387-28834-1
32,400円
Contents
* 1巻から3巻はシュードモナスの生物学を包括的にまとめ、その生息ニッチや、近縁グループとの分類学的関連、様々な環境条件化、異なるニッチでの遺伝子発現の分子生物学、植物における病原性形質の分析、ヒトを含む動物の病原体やバイオテクノロジーに応用できるもの、植物の生長を助長する菌株などを論じています。
* 第4巻は、既刊3巻に収録されなかった、病原性と病原体、ゲノミクスとプロテオミクス、そして生理学、代謝とバイオテクノロジーの分野の最新の内容を収録しています。シュードモナス、とくにその病原性やゲノミクス、生理学、バイオテクノロジーなどの研究において他に類を見ない資料です。
Contents 1. New insights on iron acquisition mechanism in pathogenic Pseudomonas/ 2. Clonal variations in Pseudomonas aeruginosa/ 3. Pseudomonas aeruginosa phospholipases and phospholipids/ 4. In vivo functional genomics of Pseudomonas: PCR-based signature-tagged mutagenesis/ 5. A genome-wide mutant library of Pseudomonas aeruginosa/ 6. Biogenesis & function of type IV pili in Pseudomonas species/ 7. Evolution of catabolic pathways in Pseudomonas through gene transfer/ 8. Controlling regiospecific oxidation of aromatics and the degradation of chlorinated aliphatics via active site engineering of toluene monooxygenases/ 9. Aromatic ring hydroxylating dioxygenases/ 10. The Pseudomonas aeruginosa genome database/ *
Ramos, J.-L. & Filloux, A. ed.
Pseudomonas Vol. 5
A Model System in Biology
Springer-Verlag 2007.
464 pp. (H)
ISBN 1-4020-6096-3
34,200円
Contents
Part 1.GENOMICS : 1. Genomics of Pseudomonas fluorescens Pf-5 / 2. Glycosilation Islands of Pseudomonas species / Part 2.PHYSIOLOGY AND METABOLISM : 3. Styrene, an unpalatable substrate with complex regulatory networks / 4. Degradation of o-xylene by Pseudomonas stutzeri OX1 (Pseudomonas sp. OX1) / 5. Carbazole metabolism by Pseudomonas / 6. The catabolism of phenylacetic acid and other related molecules in Pseudomonas putida U. / 7. Role of membrane structure during stress signalling and adaptation in Pseudomonas / Part 3.DATABASES : 8. Towards a genome-wide mutant library of Pseudomonas putida strain KT2440 / Part 4.GENE REGULATION : 9. The use of microcalorimetry to study regulatory mechanisms in Pseudomonas / 10. Cell-cell communication: Quorum sensing and regulatory circuits in Pseudomonas aeruginosa / 11. Modulation of bacteria lifestyles via two-component regulatory networks / Part 5.PATHOGENESIS : 12. Pseudomonas aeruginosa internalization by non-phagocytic cells / Part 6.CATABOLISM AND BIOTRANSFORMATIONS : 13. Histidine catabolism and catabolite regulation / 14. Synthesis and degradation of polyhydroxyalkanoates / 15. Quorum quenching acylases in Pseudomonas aeruginosa / *
Shor, A.
Chlamydia Atherosclerosis Lesion
Discovery, Diagnosis and Treatment
Springer-Verlag 2007.
170 pp.(H)
ISBN 1-84628-809-6
20,600円
Contents
1.Introduction/ 2.The Germ's Story/ 3.The Deadly Disease/ 4.Atheroma Gruel/ 5.Discovery/ 6.Which Chlamydia Species/ 7.Identification of Atheroma Germ/ 8.Publications, Presentations and Confirmation/ 9.Chlamydia are Inherent Components of Atheroma/ 10.Do Chlamydia Germs Cause Atherosclerosis?- Pathological Lesion Diagnosis/ 11.Study of Atheroma Lesions/ 12. New Findings Concerning Initial Lesion/ 13.Fatty Streak Lesion.- Formation of Fibro-Necrotic Plaque/ 14.Interpretaton of Lesion/ 15.Confirmatory Molecular Biological Studies/ 16.Derivation of Lipid in Lesion/ 17.Acceptance/ 18.Diagnosis of Atheroma Lesions/ 19.Treatment/ 20.Pathological Study/ 21.Other Studies/ 22.What Do We Know About Treatment of Atheroma Lesions/ 23.Other Treatment Possibilities/ 24.Conclusion/ index/ *
766-7 登録日 08.01.20
